In case you missed it, Johnny Garcia, PharmD, Senior Director, Policy at the Pharmaceutical Care Management Association (PCMA), explains the critical role pharmacy benefit companies play in supporting all members of the prescription drug supply chain, including retail pharmacies, in
In case you missed it, PCMA President and CEO JC Scott testified before the U.S. House Education and the Workforce Committee Subcommittee on Health, Employment, Labor, and Pensions. During Scott’s testimony, he highlighted the critical role of pharmacy benefit companies in
Last month, the IQVIA Institute held a webinar, “The Use of Medicines in the U.S. 2023.” Panelists highlighted how big drug companies set the price of the drugs they create and have the power to lower costs, as well as the
Last week, the U.S. House Ways and Means Committee Health Subcommittee held a hearing on “Why Health Care is Unaffordable: Anticompetitive and Consolidated Markets.” During the hearing, Congressman Kevin Hern (R-OK) shared that, as a former business owner, he was
A wide array of voices from across the country are calling on lawmakers to oppose recently reintroduced legislation, the Pharmacy Benefit Manager Transparency Act (S.127), which fundamentally misconstrues the role of pharmacy benefit companies, unfairly proposes to take away employers’
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on S. 1388, the “Prescription Drug Pricing for the People Act.” PCMA, the trade association for America’s pharmacy benefit managers (PBMs), today endorsed S. 1388, the “Prescription
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on a new white paper issued by the Institute for Clinical and Economic Review (ICER), “Assessment of Barriers to Fair Access:” “We appreciate ICER’s
©2024 PCMA. All Rights Reserved.
